Skip to main content
logo
Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
18.92
-0.04 (-0.21%)
At close: Apr 1, 2026, 4:00 PM EDT
18.49
-0.43 (-2.27%)
Pre-market: Apr 2, 2026, 5:44 AM EDT

Summit Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
265
Market Cap
14.67B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022705.00K-1.10M-61.03%
Dec 31, 20211.81M949.00K110.35%
Dec 31, 2020860.00K-56.23M-98.49%
Dec 31, 201957.09M--
Jan 31, 201957.09M39.54M225.24%
Jan 31, 201817.55M14.65M505.12%
Jan 31, 20172.90M--
Jan 31, 2016---
Jan 31, 2015---
Jan 31, 2014---
Jan 31, 20132.88M2.57M847.80%
Jan 31, 2010303.40K37.67K14.18%
Jan 31, 2009265.73K-5.76M-95.59%
Jan 31, 20086.03M4.00M197.42%
Jan 31, 20072.03M1.08M114.52%
Jan 31, 2006944.36K731.95K344.60%
Jan 31, 2005212.41K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Incyte5.14B
Jazz Pharmaceuticals4.27B
Genmab3.72B
BioMarin Pharmaceutical3.22B
Exelixis2.32B
Moderna1.94B
Madrigal Pharmaceuticals958.40M
Ionis Pharmaceuticals943.71M
Revenue Rankings

SMMT News

More News